HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yan Zhao Selected Research

FG 9041 (DNQX)

12/2005Ionotropic glutamatergic neurotransmission in the ventral tegmental area modulates DeltaFosB expression in the nucleus accumbens and abstinence syndrome in morphine withdrawal rats.
11/2004Blockade of ionotropic glutamatergic transmission in the ventral tegmental area attenuates the physical signs of morphine withdrawal in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yan Zhao Research Topics

Disease

362Neoplasms (Cancer)
10/2022 - 12/2002
112Inflammation (Inflammations)
12/2022 - 01/2008
99Infections
09/2022 - 12/2004
74Hepatocellular Carcinoma (Hepatoma)
10/2022 - 04/2002
71Neoplasm Metastasis (Metastasis)
10/2022 - 04/2002
67Stomach Neoplasms (Stomach Cancer)
05/2022 - 02/2002
39Wounds and Injuries (Trauma)
07/2022 - 01/2008
37Breast Neoplasms (Breast Cancer)
06/2022 - 02/2002
35Carcinoma (Carcinomatosis)
05/2022 - 12/2002
34Carcinogenesis
05/2022 - 10/2008
32Body Weight (Weight, Body)
05/2022 - 02/2009
30Obesity
12/2022 - 01/2013
29Rheumatoid Arthritis
12/2022 - 06/2002
27Acute Lung Injury
01/2022 - 05/2008
26Hypoxia (Hypoxemia)
01/2022 - 11/2012
25COVID-19
10/2022 - 01/2020
25Insulin Resistance
09/2022 - 03/2010
25Ischemia
01/2022 - 08/2007
25Atherosclerosis
11/2021 - 11/2007
24Pain (Aches)
01/2022 - 04/2006
23Fibrosis (Cirrhosis)
06/2022 - 08/2004
21Necrosis
10/2022 - 03/2005
21Lymphoma (Lymphomas)
01/2022 - 09/2005
19Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2022 - 06/2002
18Cardiovascular Diseases (Cardiovascular Disease)
08/2022 - 12/2010
18Pancreatitis
02/2022 - 08/2007
18Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2006
18Traumatic Brain Injuries (Traumatic Brain Injury)
01/2022 - 01/2009
18Immunoglobulin G4-Related Disease
01/2022 - 05/2014
18Lung Neoplasms (Lung Cancer)
01/2022 - 03/2005
18Glioma (Gliomas)
12/2020 - 01/2011
17Liver Cirrhosis (Hepatic Cirrhosis)
06/2022 - 05/2005
17Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 04/2002
17Hemorrhage
01/2022 - 10/2003
17Liver Diseases (Liver Disease)
11/2021 - 12/2007
16Heart Failure
10/2022 - 12/2004
16Hyperglycemia
09/2022 - 07/2008
16Allergic Rhinitis
03/2022 - 03/2006
16Esophageal Neoplasms (Esophageal Cancer)
11/2021 - 06/2013
15Autoimmune Diseases (Autoimmune Disease)
11/2022 - 09/2003
15Thrombosis (Thrombus)
07/2022 - 04/2007
15Stroke (Strokes)
01/2022 - 01/2012
15Virus Diseases (Viral Diseases)
01/2022 - 06/2001
14Reperfusion Injury
01/2022 - 01/2003
14Hypertension (High Blood Pressure)
01/2022 - 05/2010
14Arthritis (Polyarthritis)
10/2021 - 11/2008
14Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2008
14Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 01/2010
13Hypersensitivity (Allergy)
01/2022 - 12/2004
13Non-alcoholic Fatty Liver Disease
12/2021 - 04/2013
13Liver Neoplasms (Liver Cancer)
10/2021 - 09/2004
13Human Influenza (Influenza)
08/2021 - 08/2011
13Dyslipidemias (Dyslipidemia)
01/2021 - 02/2010
12Osteoarthritis
06/2022 - 05/2009

Drug/Important Bio-Agent (IBA)

149Proteins (Proteins, Gene)FDA Link
12/2022 - 06/2002
74Pharmaceutical PreparationsIBA
05/2022 - 09/2005
71Biomarkers (Surrogate Marker)IBA
03/2022 - 03/2010
68CytokinesIBA
10/2022 - 03/2009
56Biological ProductsIBA
09/2022 - 04/2002
56MicroRNAs (MicroRNA)IBA
01/2022 - 10/2012
52Messenger RNA (mRNA)IBA
10/2022 - 04/2003
47EnzymesIBA
12/2022 - 02/2003
36Interleukin-6 (Interleukin 6)IBA
09/2022 - 02/2013
34DNA (Deoxyribonucleic Acid)IBA
06/2022 - 02/2002
30Glucose (Dextrose)FDA LinkGeneric
09/2022 - 03/2012
27Long Noncoding RNAIBA
01/2022 - 01/2014
27RNA (Ribonucleic Acid)IBA
01/2022 - 06/2001
27Therapeutic UsesIBA
01/2022 - 11/2004
25LipidsIBA
12/2022 - 02/2010
25Immunoglobulin G (IgG)IBA
06/2022 - 04/2007
23VaccinesIBA
06/2022 - 09/2004
23GlucocorticoidsIBA
06/2022 - 02/2010
23CollagenIBA
01/2022 - 11/2006
23Peptides (Polypeptides)IBA
01/2022 - 01/2008
22AntibodiesIBA
09/2022 - 09/2004
22LipopolysaccharidesIBA
01/2022 - 01/2013
22AntioxidantsIBA
08/2021 - 05/2008
20CarbonIBA
01/2022 - 09/2014
20AntigensIBA
09/2021 - 02/2002
19Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 05/2004
18Polysaccharides (Glycans)IBA
01/2022 - 11/2011
17Small Interfering RNA (siRNA)IBA
09/2022 - 05/2008
17Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 01/2003
16CholesterolIBA
12/2021 - 01/2008
15ChemokinesIBA
10/2022 - 10/2003
15Insulin (Novolin)FDA Link
09/2022 - 11/2009
14LigandsIBA
09/2022 - 05/2008
14InflammasomesIBA
09/2022 - 07/2015
14Sorafenib (BAY 43-9006)FDA Link
01/2022 - 08/2012
13Transcription Factors (Transcription Factor)IBA
08/2022 - 04/2004
13C-Reactive ProteinIBA
04/2022 - 08/2014
13Interleukin-17 (Interleukin 17)IBA
02/2022 - 03/2012
13Immunosuppressive Agents (Immunosuppressants)IBA
11/2021 - 10/2010

Therapy/Procedure

154Therapeutics
09/2022 - 06/2002
47Drug Therapy (Chemotherapy)
01/2022 - 04/2002
21Chinese Traditional Medicine (Traditional Chinese Medicine)
02/2022 - 03/2010
20Radiotherapy
01/2022 - 12/2002
17Aftercare (After-Treatment)
06/2022 - 09/2011
16Neoadjuvant Therapy
04/2022 - 09/2013
16Immunotherapy
01/2022 - 03/2008